跳到主要內容

Lerer Kenneth B 的 Form 4 申報

Strata Critical Medical, Inc.(SRTA),2022/6/2 申報

申報編號
0000899243-22-020767
申報時間
2022/6/2
交易日
2022/5/31-6/2
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $205.1 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Lerer Kenneth BCIK 0001120789董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/5/31Class A common stock, $0.0001 par value per shareS賣出處分−30,989$7.06F1−$218,782.34467,123間接
2022/5/31Class A common stock, $0.0001 par value per shareS賣出處分−16,582$7.06F1−$117,068.92249,962間接
2022/6/1Class A common stock, $0.0001 par value per shareS賣出處分−1,297$7.01F5−$9,091.97465,826間接
2022/6/1Class A common stock, $0.0001 par value per shareS賣出處分−694$7.01F5−$4,864.94249,268間接
2022/6/2Class A common stock, $0.0001 par value per shareS賣出處分−150,961$7.34F6−$1,108,053.74314,865間接
2022/6/2Class A common stock, $0.0001 par value per shareS賣出處分−80,780$7.34F6−$592,925.2168,488間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

These transactions were executed in multiple trades at prices ranging from $7.00 to $7.18, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.

表 I 有 2 筆交易的價格引用這則附註。

F5

These transactions were executed in multiple trades at prices ranging from $7.000 to $7.045, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.

表 I 有 2 筆交易的價格引用這則附註。

F6

These transactions were executed in multiple trades at prices ranging from $7.03 to $7.45, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.

表 I 有 2 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)